A randomized, double-blind, placebo-controlled trial of ramosetron for preventing nausea and vomiting during termination of pregnancy

International Journal of Obstetric Anesthesia

Volumn 13, Issue 1, 2004, Pages 15-18

  Fujii, Y ^a,b   Tanaka, H ^a   Somekawa, Y ^a  

^a Toride Kyodo General Hospital   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; INDOMETACIN; ISOTHIPENDYL; NITROUS OXIDE; PLACEBO; RAMOSETRON; SEROTONIN ANTAGONIST; SEVOFLURANE;

ADULT; ADVERSE DRUG REACTION; ANTIEMETIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CURETTAGE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENERAL ANESTHESIA; HEADACHE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; POSTOPERATIVE COMPLICATION; PREGNANCY TERMINATION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SYMPTOM; VOMITING;

EID: 0347719650     PISSN: 0959289X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-289X(03)00101-8     Document Type: Article

References (17)

1. Watcha M F, White P F. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 1992; 77: 161-184.
2. McCormick C G. FDA alert: current FDA report on droperidol status and basis for "Black Box" warning. ASA Newsletter 2002; 66: 19.
3. Lesser J, Lip H. Prevention of postoperative nausea and vomiting using ondansetron, a new, selective, 5-HT3 receptor antagonist. Anesth Analg 1991; 72: 751-755.
4. Tramer M R, Moore R A, Reynolds D J M et al. A quantitative systematic review of ondansetron in the treatment of established postoperative nausea and vomiting. BMJ 1997; 314: 1088-1092.
5. Kawabata Y, Sakiyama H, Muto S et al. Clinical evaluation and pharmacokinetics of ramosetron against the nausea and vomiting induced anticancer drugs. Nishinihon J Urol 1994; 56: 1445-1456,
6. Noda K, Ikeda M, Yoshida O et al. Clinical evaluation of ramosetron against the nausea and vomiting induced anticancer drugs. Jpn J Clin Exp Med 1994; 71: 2765-2776.
7. Fujihara A, Akuzawa S, Miyata K et al. Ramosetron hydrocloride: affinity for cloned human 5-HT3 receptor antagonistic and antiemetic effect in ferret. Kiso to Rinsho 1996; 30: 1965-1972.
8. Fujii Y, Tanaka H. Comparison of granisetron and ramosetron for the prevention of nausea and vomiting after thyroidectomy. Clin Ther 2002; 24: 766-772.
9. Fujii Y, Tanaka H. Double-blind, placebo-controlled, dose-ranging study of ramosetron for the prevention of nausea and vomiting after thyroidectomy. Clin Ther 2002; 24: 1148-1153.
10. Fujii Y, Uemura A, Tanaka H. Prophylaxis of nausea and vomiting after laparoscopic cholecystectomy with ramosetron: randomised controlled trial. Eur J Surg 2002; 168: 583-586.
11. Fujii Y, Tanaka H, Ito M. Ramosetron compared with granisetron for the prevention of vomiting following strabismus surgery in children. Br J Ophthalmol 2001; 85: 670-672.
12. Fujii Y, Saitoh Y, Kobayashi N. Prevention of vomiting after tonsillectomy in children: granisetron versus ramosetron. Laryngoscope 2001; 111: 255-258.
13. McKenzie R, Wadhwa R K, Uy N T L et al. Antiemetic effectiveness of intramuscular hydroxyzine compared with intramuscular droperidol. Anesth Analg 1981; 60: 783-788.
14. Madej T H, Simpson K H. Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following gynaecological surgery in day cases. Br J Anaesth 1986; 58: 879-883.
15. Hartung J. Twenty-four of twenty-seven studies show a greater incidence of emesis with nitrous oxide than with alternative anesthetics. Anesth Analg 1996; 83: 114-116.
16. Fisher D M. Does nitrous oxide cause vomiting? Anesth Analg 1996; 83: 4-5.
17. Tramer M, Moore A, McQuay H. Omitting nitrous oxide in general anaesthesia: meta-analysis of intraoperative awareness and postoperative emesis in randomized controlled trials. Br J Anaesth 1996; 76: 186-193.